StockWatch
·

Borosil Renewables Ltd Q2 FY27 Results

BORORENEWQ2 FY27 Results
Filing
Result:Poor· Market: Flat#Margin squeeze#Base effect#Cost led

Outlook: Optimistic · Guidance: Cut

MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue396.702.2%4.7%
Total Income407.592.9%7.1%
Expenditure317.725.1%11.0%
PBT89.8623.4%3.5%
Net Profit68.7820.6%11.7%
OPM26.55%4.80pp2.71pp
NPM16.87%3.77pp0.70pp
EPS4.7822.8%141.4%
View full financials

Adjusted PAT is roughly flat YoY (-0.8%) once the prior-year German-subsidiary impairment base effect is stripped out, with revenue growth only 4.7% and EBITDA margin falling sharply from ~31.3% to ~26.6% QoQ on cost-led power/fuel and employee expense inflation outpacing revenue.

BOROSIL RENEWABLES · Q2 FY27 · THE VERDICT

60% Growth Set, Margins Reset Lower—Cost Inflation and Furnace Downtime the Near-Term Anchors

Borosil's ₹1,100 crore expansion (600-TPD plant, Q4 FY27 commissioning) is credible and riding genuine solar glass demand tailwinds. But Q2 EBITDA margin collapsed 380 bps below guidance, Q2 revenue fell QoQ despite management bullishness, and cost inflation remains unresolved. The stock has priced in the disappointment—down 54% from ATH—but the operational test of margin recovery and new plant ramp remains.

04 Nov 2026 · 6 min read
Q2 EBITDA margin

29.3%

-380 bps vs 33%+ guided

Q2 revenue QoQ

₹396.7 Cr

-2.2% vs ₹405.7 in Q1

H1 FY27 growth

12.8% YoY

vs 53% prior guidance

Borosil's earnings split cleanly into two frames this quarter. The long-term one is compelling: a ₹1,100 crore capacity expansion (600 TPD new plant, Q4 FY27 commissioning) riding genuine tailwinds in solar glass (62 GW demand, only 18 GW domestic supply). The near-term one is painful: EBITDA margin of 29.3% missed guidance by 380 basis points, Q2 revenue fell 2.2% quarter-over-quarter despite management optimism, and leadership has quietly reset margin expectations down from 33%+ to 31%-32%. That gap—between promise and delivery—is the truth investors must grapple with.

The margin collapse: temporary pain plus structural cost inflation

Q2 EBITDA margin of 29.3% was 380 bps below the 33%+ guidance from the Q1 call. Management cites two culprits: (1) a 4.5% production dip from furnace maintenance, claimed to be temporary, and (2) cost inflation (soda ash +10%, imported dolomite/limestone +10% from China tariffs and freight). The furnace issue should reverse; the cost inflation will not. Gross margin compressed 400–500 basis points in Q2 vs Q1, and while management has committed to offsetting this via domestic sourcing and productivity gains, no quantified plan or timeline exists. Soda ash prices remain elevated. Pass-through to customers is limited by market pricing. Result: EBITDA margin guidance has been reset to 31%-32%, with a floor of 30%. Recovery back to 33%+ is no longer on the table.

Soda ash prices up 10% but negotiated; dolomite/limestone imported at 10% higher cost due to China tariffs and freight. Limited pass-through model due to market pricing. Plan to increase domestic sourcing (currently 30-40%, target ~60%) and productivity gains to offset.
Management's Q2 claims vs. what the numbers actually show

EBITDA margin consistently above 33%

Q2 consolidated 29.3%; H1 now guided 31%-32% (down from 33%+)

Overstated

Production dipped 4.5% due to maintenance; recovery underway

Revenue fell 2.2% QoQ; solar glass volumes down vs Q1; recovery not yet visible

Contradicted

60% sales growth expected post new plant Q4 FY27 commissioning

Quantified (600 TPD, ₹1,100 Cr capex, ₹349 Cr spent, on track); demand backdrop real; absorption untested

Supported (conditional)

Capex ₹1,100 Cr fully funded: ₹800 Cr internal + ₹300 Cr debt

Confirmed; building complete, installation starting end-Q4; no further debt planned

Supported

Rooftop solar business targeting ₹100 Cr revenue by end FY27

Early-stage (4 states, projects signed, distributors appointed); revenue unproven at scale; aspirational target

Partial

What changed from Q1 guidance

Four material shifts in management expectations:
  • EBITDA margin guidance cut from 33%+ to 31%-32% (floor 30%)

  • Capex increased ₹150 Cr to ₹1,100 Cr total (exchange 20%, power redundancy)

  • Furnace maintenance quantified: 75 days per existing furnace in H1 FY28; new plant offset claimed

  • Rooftop solar ambition upsized: from ₹36 Cr (Q1 implied) to ₹100 Cr FY27-end

How the market is reading this

The stock has priced in disappointment. At ₹378.65 (as of 2026-11-03), Borosil trades 54.56% below its all-time high of ₹833.35. RSI of 23.5 signals deep oversold conditions; the stock sits below its 20-day, 50-day, and 200-day simple moving averages. The day-1 post-result reaction was flat (−0.06%)—no panic selling, but no relief rally either. This is the market's statement that the expansion thesis survives on valuation, but the operational test is not yet passed. One institutional bright spot: foreign portfolio investors have raised stakes to 6.14% from 4.27% a quarter ago, a 187 bps accumulation into weakness. This suggests selective buying at depressed valuations, but volume is normal and delivery patterns unremarkable. The tape's verdict: margin miss and growth reset are accepted; proof of new plant ramp and margin recovery is required before re-rating.

The bull-bear ledger

The bull case rests on:
  • Structural solar glass supply gap: 62 GW annual demand, only 18 GW domestic supply

  • 600-TPD new plant (₹1,100 Cr capex) real, on-track (₹349 Cr spent), demand-backed

  • 60% revenue growth post-commissioning credible at current ₹155–160/mm ex-factory pricing

  • Capex fully funded internally + committed debt; no balance sheet stress

  • H1 FY27 revenue +12.8% YoY despite Q2 furnace dip; demand trajectory intact

The bear case warns:
  • EBITDA margin miss (29.3% vs 33%+ guided) signals execution risk, not just temporary pain

  • Cost inflation (soda ash, freight, China tariffs) may persist; pass-through limited by market pricing

  • Q2 revenue fell 2.2% QoQ despite near-term management optimism—furnace impact undersold

  • 60% growth depends on absorbing 600 TPD at ₹155–160/mm; demand at that volume unproven; pricing risk real

  • Rooftop ₹100 Cr target aspirational for early-stage (4 states); business model unproven at scale

  • Furnace downtime H1 FY28 (75 days) creates a 12-month production and profitability gauntlet

The honest read: Borosil is not a broken story. The demand tailwind is structural, not cyclical. Capex is credible and de-risked on the balance sheet. But the next 18 months are a test. Cost inflation is unresolved. Furnace downtime in H1 FY28 will compress volumes by ~₹15 crore; the new plant is the offset, but timing and ramp-up are execution risks. Margin recovery from 29.3% toward the guided 31%-32% band is the prove-it metric. If Q3-Q4 show 50+ bps sequential improvement, the long-term thesis re-rates. If margins stay <30%, the expansion thesis loses margin leverage, and growth alone becomes insufficient to justify the ₹1,100 crore capex. For existing holders, the bar is clear: hold if you see Q3 margin recovery and new plant progress on schedule. For new money, ₹378.65 looks optically cheap (down 54% from ATH, RSI 23.5 deeply oversold), but the operational prove-it is required first. Don't chase valuation; wait for execution proof.

Risks, ranked by how much they should concern a holder

Structural margin compression; cost inflation not fully offset

High

Soda ash +10%, imported materials +10%, limited pass-through. Guidance cut from 33%+ to 31%-32%; Q2 landed 29.3%. If Q3-Q4 don't recover to 31%+, the 60% growth thesis requires lower absolute EBITDA margins, which compresses FY28 profit expansion and return on the ₹1,100 Cr capex.

New plant utilization risk; 600 TPD demand absorption unproven

High

60% growth assumes full 600 TPD sold at ₹155–160/mm in a competitive market. Structural supply gap is real, but absorbing that incremental volume without price compression is not guaranteed. Module makers may integrate glass in-house; pricing could compress under volume pressure. No forward contracts disclosed.

Furnace downtime H1 FY28; new plant timing and ramp-up risk

Medium

Existing furnaces (7-year-old SG1 and SG2) require 75-day maintenance each in H1 FY28. Estimated ₹15 Cr revenue loss. New plant (commissioned Q4 FY27) is the offset, but if installation slips or ramp is slower than expected, output gap opens and FY28 growth guidance misses.

Rooftop solar business execution and profitability unclear

Medium

₹100 Cr FY27 revenue target is aspirational for an early-stage distributor model (4 states launched). Profitability path vague; trading model margins typically low. If scaling stalls, margins disappoint, or distribution breaks down, the FY28 diversification thesis withers and overall growth lags.

Capex cost escalation beyond ₹1,100 Cr

Medium

Capex already upsized ₹150 Cr (exchange 20%, power supply redundancy). Exchange volatility, material inflation, or labor overruns could push total beyond ₹1,100 Cr, pressuring the debt ceiling and reducing return on capex in early years.

What to watch next

Three concrete catalysts that resolve the debate
  • 1 · Q3 FY27 EBITDA margin recovery (Jan 2027 results)

    Management expects recovery to 30%+ by Q3 (Oct–Dec 2026). New furnaces fire in Feb–March; production ramp to historically high levels expected. Watch for 50+ bps sequential improvement from Q2's 29.3%. If Q3 lands <30%, or if margin recovery is <30 bps, the 31%-32% guidance becomes doubtful, and the margin reset becomes structural rather than temporary.

  • 2 · New plant commissioning and production ramp (Q4 FY27, Feb–Mar 2027)

    Building is complete; machinery delivery and installation starting end-Q4 FY27. Any delays beyond March 2027 push commissioning into Q1 FY28 and compress the production run before furnace downtime. Monitor capex milestones, installation progress, and any further cost escalations. On-time commissioning by March 2027 is the prerequisite for 60% revenue growth in FY28.

  • 3 · Rooftop solar business traction and unit economics (year-end FY27 update)

    ₹100 Cr revenue target by end-FY27 is the test. Distributors active in 4 states; projects signed but not yet converted to revenue. Watch for: (a) run-rate revenue by Dec 2026, (b) gross margin and EBITDA margin profile for the rooftop segment, (c) geographic expansion plans for FY28. If FY27-end update shows <₹30 Cr annualized run-rate or margins <8%, the ₹100 Cr target evaporates and FY28 guidance revises down.

Borosil is executing a credible expansion into genuine solar glass demand tailwinds. The long-term thesis holds. But the near-term—Q3 to H1 FY28—is a gauntlet of cost inflation, furnace maintenance, and unproven new-plant demand absorption. Management's margin reset from 33%+ to 31%-32% is honest but reflects execution risk, not just temporary headwinds.

For existing holders: the thesis survives if Q3 margin recovery is visible and new plant stays on track. For new money: ₹378.65 is optically cheap (RSI 23.5 oversold, -54% from ATH), but the operational prove-it is required first. Don't chase valuation into uncertainty.

The number to track: Q3 EBITDA margin. If it closes the gap toward 31%-32%, the long-term bull case re-rates and FY28 guidance gains credibility. If it stays below 30%, the expansion thesis loses margin leverage, and growth alone becomes insufficient to justify the ₹1,100 crore capex spend. That single line item is the hinge of the entire story.

Informational and educational content only. Not investment advice.